Concepedia

Ikumi Nakajo

IN

Statistics

Publications

3

Citations

148

H-Index

3

Active since

2005

Affiliations

Astellas Pharma (Japan)(Current)

Ikumi Nakajo is an author at Astellas Pharma (Japan) specializing in pharmacology, cytochrome p450 enzymes, and transcriptional activation.

Publications per year

2005–2024

3

Publications

3

IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR

Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki et al. · Drug Metabolism and Disposition · 2005 · 68 citations

, , +17

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD

Tobias E. Larsson, Chisato Kameoka, Ikumi Nakajo et al. · Kidney International Reports · 2017 · 63 citations · Full text

, , +17

Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models

Toshihide Nishibata, Jane Weng, Keisuke Omori et al. · Journal of Pharmacological Sciences · 2024 · 17 citations · Full text

, , +17

1–3 of 3